Evidence map›Paper›PMID 41254145›Full record

ArticleCommunications medicine2025

Using genomic context informed genotype data and within-model ancestry adjustment to classify type 2 diabetes.

Eric J Barnett, Yanli Zhang-James, Jonathan L Hess, Stephen J Glatt, Stephen V Faraone

Abstract read
In one paragraph

Article in Communications medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eric J BarnettDepartment of Psychiatry and Behavioral Sciences and Department of Neuroscience and Physiology, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.
Yanli Zhang-JamesDepartment of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.ORCID http://orcid.org/0000-0002-2104-0963
Jonathan L HessDepartment of Psychiatry and Behavioral Sciences, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.ORCID http://orcid.org/0000-0001-8406-632X
Stephen J GlattDepartment of Psychiatry and Behavioral Sciences and Department of Neuroscience and Physiology, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA.
Stephen V FaraoneDepartment of Psychiatry and Behavioral Sciences and Department of Neuroscience and Physiology, Norton College of Medicine at SUNY Upstate Medical University, Syracuse, NY, USA. svfaraone@upstate.edu.ORCID http://orcid.org/0000-0002-9217-3982

Funding

SLE Treatment with N-acetylcysteineU01AR076092 · NIAMS · UPSTATE MEDICAL UNIVERSITY · PI Michael P McDermott, Andras Perl · 2020 to 2026
$7.9M
Person-centered diagnostics and prediction for child dysregulatory psychopathology using novel phenotypesU01MH135970 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI KARALUNAS, SARAH LYN, NAGEL, BONNIE J. · 2024 to 2025
$6.5M
Discoveries in ADHD genomics: Help or hype in clinical settings?R01MH116037 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI DOYLE, ALYSA E · 2019 to 2023
$4.4M
Genetic Predictors, Transcriptomic Biomarkers, & Neurobiological Signatures of Resilience to Alzheimer's DiseaseR01AG064955 · NIA · UPSTATE MEDICAL UNIVERSITY · PI FENNEMA-NOTESTINE, CHRISTINE, GLATT, STEPHEN J · 2019 to 2023
$3.8M
Longitudinal Family/Molecular Genetic Study to Validate Research Domain CriteriaR01MH101519 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI FARAONE, STEPHEN V, GLATT, STEPHEN J · 2014 to 2018
$3.5M
Polygenic and environmental contributions to ADHD trajectory and outcome from childhood through adolescenceR01MH131685 · NIMH · OREGON HEALTH & SCIENCE UNIVERSITY · PI Michael A Mooney, Molly Nikolas · 2023 to 2026
$3.1M
Leveraging computational strategies to disentangle the genetic and neural underpinnings of ADHD and its associated cognitive systemsR01MH130899 · NIMH · MASSACHUSETTS GENERAL HOSPITAL · PI Tian Ge · 2023 to 2026
$3.0M
Gene Expression Biomarkers for Early Identification of Mild Cognitive Impairment: A Twin StudyR01AG054002 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLATT, STEPHEN J, TSUANG, MING T. · 2016 to 2019
$2.7M
Integrating Genetic, Neuroimaging, Transcriptomic, and Clinical Risk Factors as Multivariate Predictors of Cognitive Deterioration in Alzheimer's Disease.R01NS128535 · NINDS · UPSTATE MEDICAL UNIVERSITY · PI HESS, JONATHAN · 2022 to 2024
$1.2M
Profiling the Functional Genetics of Health and Disease using BrainGENIE: The Brain Gene Expression and Network Imputation EngineR21MH126494 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI GLATT, STEPHEN J, HESS, JONATHAN · 2021 to 2022
$446k
NIAMS NIH HHS U01 AR076092NIA NIH HHS R01 AG054002NIA NIH HHS R01 AG064955NIMH NIH HHS R01 MH101519NIMH NIH HHS R01 MH116037NIMH NIH HHS R01 MH130899NIMH NIH HHS R01 MH131685NIMH NIH HHS R21 MH126494NIMH NIH HHS U01 MH135970NINDS NIH HHS R01 NS128535Wellcome Trust
6 · The paper itself

Abstract

backgroundDespite high heritability estimates, complex genetic disorders have proven difficult to predict with genetic data. Genomic research has documented polygenic inheritance, cross-disorder genetic correlations, and enrichment of risk by functional genomic annotation, but the vast potential of that combined knowledge has not yet been leveraged to build optimal risk models. Additional methods are likely required to progress genetic risk models of complex genetic disorders towards clinical utility.

methodsWe developed a modeling framework that uses annotations providing genomic context alongside genotype data as input to convolutional neural networks. To test this framework, we used a matched-pairs dataset of individuals with and without type 2 diabetes. We compared the performance of models trained on genotype data alone to those trained on context-informed genotype data. We also introduced adversarial tasks to remove the ability of models to predict genetic ancestry while assessing whether risk prediction performance was preserved.

resultsHere, we show that a neural network using genotype data (AUC: 0.66) and a convolutional neural network using context-informed genotype data (AUC: 0.65) both significantly outperform polygenic risk score approaches in classifying type-2 diabetes. Adversarial ancestry tasks eliminate the predictability of ancestry without changing model performance.

conclusionsWe present neural network approaches that improve classification performance by integrating genotype data with genomic context while accounting for ancestry. Although current performance is not yet sufficient for clinical use in type 2 diabetes, incremental advances such as these may help move genetic risk prediction toward future clinical utility.

Identifiers

PMID41254145
PMCPMC12627480

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.